| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |